On this special episode of the podcast, Emilia Javorsky interviews Sean Ekins about regulating AI drug discovery.
Timestramps:
00:00 Introduction
00:31 Ethical guidelines and regulation of AI drug discovery
06:11 How do we balance innovation and safety in AI drug discovery?
13:12 Keeping dangerous chemical data safe
21:16 Sean’s personal story of voicing concerns about AI drug discovery
32:06 How Sean will continue working on AI drug discovery
Anthony Aguirre of the Future of Life Institute discusses A Better Path for AI, arguing against races to replace people and for purpose-built AI tools with human control, guardrails, accountability, and international cooperation.
View episode
Charlie Bullock discusses radical optionality, a framework for governing advanced AI under uncertainty. The episode covers transparency, evaluations, cybersecurity, technical hiring, and tensions between private and government oversight.
View episode
Peter Wildeford discusses methods for forecasting AI progress and why he sees AI as neither a bubble nor a normal technology, covering economic effects, national security, cyber capabilities, robotics, export controls, and prediction markets.
View episodeNo matter your level of experience or seniority, there is something you can do to help us ensure the future of life is positive.
